P42 peptide (CNRS/University of Montpellier)

N/A

Report date: 2025/01/26 16:39:50

Base Information

Drug NameP42 peptide (CNRS/University of Montpellier)
Drug Alias NameP42 peptideP42-TAT fusion peptide (CNRS/University of Montpellier)NP42T
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHuntingtin inhibitors
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesCNRS InnovationUniversity of MontpellierCentre National De La Recherche Scientifique (Cnrs)
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A